跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TARO-MEROPENEM - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TARO-MEROPENEM
Authorized
STANDARD
TARO-MEROPENEM
sun pharma canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8a698a88c733e26f
Company
sun pharma canada inc
Type
Standard
Approval Details
Approval Id
8a698a88c733e26f
Drug Approval Canada Name
TARO-MEROPENEM
Product Name
TARO-MEROPENEM
Status
Marketed
Status Date
2021-06-11
Original Market Date
2021-06-11
Din
02421526
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:12.07.08
Atc Original
J01DH02 MEROPENEM
Atc Name
j 01 dh 02
Aig Number
0128599003
Company Name
sun pharma canada inc
Company Address
126 East Drive, Brampton, Ontario, Canada, L6T 1C1
Active Ingredients
MEROPENEM (MEROPENEM TRIHYDRATE)
1 G / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8a698a88c733e26f
Type
Standard
Back to Health Canada Approvals